로딩 중…
지수 로딩 중…
AxoGen, Inc.
AXGN· NASDAQ· Health Care· Health Care Equipment & Services
$45.73+8.34%
2026-08-03
Financials
Valuation Metrics
AxoGen, Inc.'s Market Cap is $2.43B. At end of 2025 it was $1.54B. Ranked #1922 of 3,112 in US market (top 62%), #713 of 1,445 on NASDAQ (top 49%), #112 of 206 in Health Care Equipment & Services (top 54%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.43B | US#1,922/3,112 Sec#112/206 |
| Revenue | $251M | US#2,620/3,112 Sec#168/206 |
| Net Income | $-34M | US—/3,112 Sec—/206 |
| Total Assets | $305M | US#2,893/3,112 Sec#176/206 |
| Net Assets | $256M | US#2,627/3,112 Sec#158/206 |
| Value | ||
| P/B | 9.49x | US#2,591/3,112 Sec#171/206 |
| P/S | 9.68x | US#2,641/3,112 Sec#185/206 |
| FCF Yield | 0.10% | US#2,239/3,112 Sec#144/206 |
| Profitability | ||
| ROE | -13.09% | US#2,452/3,112 Sec#141/206 |
| ROA | -11.00% | US#2,658/3,112 Sec#158/206 |
| Op. Margin | -5.12% | US#2,569/3,112 Sec#150/206 |
| Revenue Growth | 23.06% | US#651/3,112 Sec#38/206 |
| Earnings Growth | -361.83% | US#2,298/3,112 Sec#121/206 |
| Financial Health | ||
| Debt Ratio | 18.97% | US#210/3,112 Sec#21/206 |
| Total Debt | $20M | US#2,702/3,112 Sec#172/206 |
| FCF | $3M | US#2,248/3,112 Sec#144/206 |
| Cash | $95M | US#2,249/3,112 Sec#144/206 |
| Current Ratio | 6.60x | US#364/3,112 Sec#25/206 |
| Performance | ||
| 1Y Return | 260.93% | US#62/3,112 Sec#3/206 |
| 1M Return | -0.35% | US#1,699/3,112 Sec#114/206 |
| From 52W High | -2.60% | US#285/3,112 Sec#17/206 |
| 1Y MDD | -19.30% | US#637/3,112 Sec#11/206 |
| Trading | ||
| Volume | 1,390,021 shares | US#1,185/3,112 Sec#71/206 |
| Trading Value | $62M | US#1,216/3,112 Sec#93/206 |
| Per Share | ||
| EPS | $-0.33 | US—/3,112 Sec—/206 |
| BPS | $2.75 | US#2,448/3,112 Sec#165/206 |